Part I. Analysis of data gaps pertaining to Salmonella enterica serotype Typhi infections in low and medium human development index countries, 1984-2005

Epidemiology and Infection

Volumn 136, Issue 4, 2008, Pages 436-448

  Crump, J A ^a   Ram, P K ^a   Gupta, S K ^a   Miller, M A ^b   Mintz, E D ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; POLYSACCHARIDE VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TYPHOID VACCINE;

AGE DISTRIBUTION; ARTHROPATHY; BACTERIUM IDENTIFICATION; BONE DISEASE; BONE MARROW CULTURE; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; DISEASE DURATION; EPIDEMIOLOGICAL DATA; GEOGRAPHIC DISTRIBUTION; HEALTH SERVICE; HEMATOLOGIC DISEASE; HEPATOBILIARY DISEASE; HUMAN; INCIDENCE; INFECTION PREVENTION; INTESTINE PERFORATION; LUNG DISEASE; MORBIDITY; MORTALITY; REVIEW; RISK FACTOR; SALMONELLA TYPHI; SENESCENCE; SEX DIFFERENCE; SOFT TISSUE INFECTION; TYPHOID FEVER; UROGENITAL TRACT DISEASE;

AGE DISTRIBUTION; DEVELOPING COUNTRIES; HUMANS; INCIDENCE; POPULATION SURVEILLANCE; SALMONELLA TYPHI; TYPHOID FEVER; WORLD HEALTH;

EID: 40449090067     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268807009338     Document Type: Review

References (84)

1. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bulletin of the World Health Organisation 2004; 82: 346-353.
2. Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases, 6th edn. New York, NY: Elsevier/Churchill Livingstone, 2005.
3. Heymann DL. Control of Communicable Diseases Manual, 18th edn. Washington, DC: American Public Health Association, 2004.
4. Reller ME, et al. Sexual iransimission of typhoid fever: A multistate outbreak among men who have sex with men. Clinical Infectious Diseases 2003; 37: 141-144.
5. Hornick RB, Woodward TE. Appraisal of typhoid vaccine in experimentally infected human subjects. Transactions of the American Clinical and Climatological Association 1967; 78: 70-78,
6. Murray PR, et al. Manual of Clinical Microbiology, 8th edn. Washington, DC: ASM Press, 2003, pp. 2310.
7. Crump JA, et al. Estimating the incidence of typhoid fever and other febrile illnesses in developing countries. Emerging Infectious Diseares 2003; 9: 539-544.
8. Butler T, et al. Typhoid fever complicated by intestinal. perforation: A persisting fatal disease requiring surgical management. Reviews of Infectious Diseases 1985; 7: 244-256.
9. Hosoglu S, et al. Risk factors for enteric perforation in patients with typhoid fever. American Journal of Epidemiology 2004; 160: 46-50.
10. Khan M, et al. Influence of sex on clinical features, laboratory findings, and complications of typhoid fever. American Journal of Tropical Medicine and Hygiene 1999; 61: 41-46.
11. Huang DB, DuPont HL. Problem pathogens: Extra-intestinal complications of Salmonella enterica serotype Typhi infection. Lancet Infectious Diseases 2005; 5: 341-348.
12. Mermin JH, et al. A massive outbreak of multidrug-resistant typhoid fever in Tajikistan associated with consumption of municipal water. Journal of Infectious Diseases 1999, 179: 1416-1422.
13. van den Bergh ETAM, et al. Outcome in three groups of patients with typhoid fever in Indonesia between 1948 and 1990. Tropical Medicine and International Health 1999; 4, 211-215.
14. Sinha A, et al. Typhoid fever in children aged less than 5 years. Lancet 1999; 354: 734-737.
15. Brooks WA, et al. Bacteremic typhoid fever in an urban slum, Bangladesh. Emerging Infectious Diseases 2005; 11: 326-329.
16. Ferreecio C, et al. Benign bacteremia caused by Salmonella Typhi and Paratypi in children aged younger than 2 years. Journal of Pediatrics 1984; 104 899-900.
17. Mulligan TO. Typhoid fever in young children. British Medical Journal 1971; 4: 665-667.
18. Arora RK, et al. Multidrug resistant typhoid fever: Study of an outbreak in Calcutta. Indian Pediatrics 1992; 29: 61-66.
19. Bhutta ZA. Impact ofage and drug resistance on mortality in typhoid fever. Archives of Diseases in Childhood 1996; 75: 214-217.
20. Butler T, et al. Patterns of morbidity and mortality in typhoid fever dependent on age and gender: Review of 552 hospitalized patients with diarrhea. Reviews of Infectious Diseases 1991; 13 85-90.
21. Hunter GW, Strickland GT, Magill AJ. Hunter's Tropical Medicine and Emerging Infectious Diseases, 8th edn. Philadelphia: W.B. Saunders Company, 2000, pp. 1192.
22. Battikhi MN. Occurence of Salmonella Typhi and Salmonella Paratyphi in Jordan. New Microbiology 2003; 26: 363-373.
23. Saba SK, et al. Typhoid fever in Bangladesh: Implications for vaccination policy. Pediatric Infectious Diseases 2001; 20 521-524.
24. Lin F-YC, et al. The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam. American Journal of Tropical Medicine and Hygiene 2000; 62: 644-648.
25. Mirza SH, Beeching NJ, Hart CA. The prevalence and clinical features of multi-drug resistant Salmonella Typhi infections in Baluchistan, Pakistan. Annals of Tropical Medicine and Parasitology 1995: 89: 515-519.
26. Ivanoff B, Levine MM, Lambert PH. Vaccination against typhoid fever: Present status. Bulletin of the World Health Organisation 1994; 72: 957-971.
27. Acharya IL, et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella Typhi. New England Journal of Medicine 1987; 317: 1101-1104.
28. Klugman KP, et al. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet 1987; 2 1165-1169.
29. Levine MM, et al. Duration of efficacy of Ty21a, attenuated Salmonella Typhi live oral vaccine. Vaccine 1999; 17 (Suppl. 2): S22-27.
30. Centers for Disease Control and Prevention. Typhoid immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Reports 1994; 43: 1-8.
31. Lin FY, et al. The efficacy of a Salmonella Typhi Vi conjugate vaccine in two-to-five-year-old children, New England Journal of Medicine 2001; 344: 1263-1269.
32. Lanh MN, et al. Persistent efficacy of Vi conjugate vaccine against typhoid fever in Young children. New England Journal of Medicine 2003; 349: 1390-1391.
33. Bodhidatta L, et al. Control of typhoid fever in Bangkok, Thailand, by annual immunization of schoolchildren with parenteral typhoid vaccine. Reviews of Infectious Diseases 1987; 9: 841-845.
34. Gupta A, et al. Evaluation of community-based serlologic screening for identification of chronic Salmonella Typhi carriers in Vietnam. International Journal of Infectious Diseases 2006; 10: 309-314.
35. Cabello F, Springer AD. Typhoid fever in Chile 1977-1990: An emergent disease. Revista Medica de Chile 1997; 125: 474-882.
36. Wolff M. Changes in the epidemiology of infectious diseases in Chile from 1990 to 2000, Revista Medica de Chile 2002; 130: 353-362.
37. Yang HH, et al. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China. Bulletin of the World Health Organisation 2001; 79: 625-631.
38. Luby SP, et al. Risk factors for typhoid fever in an endemic setting, Karachi, Pakistan. Epidemiology and Infection 1998; 120: 129-138.
39. Vollaard AM, et al. Risk factors for typhoid and paratyphoid fever in Jakarta, Indonesia. Journal of the American Medical Association 2004; 291: 2607-2615.
40. Gilman RH, et al. Relative efficacy of blood, urine, rectal swab, bone-marrow and rose-spot cultures for recovery of Salmonella Typhi in typhoid fever. Lancet, 1975; 1: 1214-1213.
41. Hoffman SL, et al. Bone marrow aspirate culture superior to streptokinase clot culture and 8 mL 1:10 blood-to-broth ratio blood culture for diagnosis of typhoid fever. American Journal of Tropical Medicine and Hygiene 1986; 35: 836-839.
42. Wain J, et al. Quantitation of bacteria in bone marrow from patients with typhoid fever: Relationship between counts and clinical features. Journal of Clinical Microbiology 2001; 39: 1571-1576.
43. Crump JA, et al. Reevaluating fluoroquinolone break-points for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. Clinical Infectious Diseases 2003, 37: 75-81.
44. Olsen SJ, et al. Evaluation of rapid diagnostic tests for typhoid fever. Journal of Clinical Microbiology 2004; 42: 1885-1889.
45. Srikantiah P, et al. Population-based surveillance of typhoid fever in Egypt. American Journal of Tropical Medicine and Hygiene 2006; 74: 114-119.
46. Klugman KP, et al. Immunogenicity, efficacy, and serological correlate of protection of Salmonella Typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine 1996; 14: 435-438.
47. Simanjuntak, CH, et al. Oral immunisation against typhoid fever in Indonesia-with Ty21a vaccine. Lancet 1991; 338: 1055-1059.
48. Levine MM, et al. Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation. Lancet 1987; 1: 1049-1052.
49. Levine MM, et al. Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial. Lancet 1990; 336: 891-894.
50. Black RE, et al. Efficacy of one or two doses of Ty21a Salmonella Typhi vaccine in enteric-coated capsules in a controlled field trial. Vaccine 1990; 8: 81-84.
51. Wahdan MH, et al. Controlled field trial of a typhoid vaccine prepared with a nonmotile mutant of Salmonella Typhi Ty2. Bulletin of the World Health Organisation 1975; 52: 69-73.
52. Wahdan MH, et al. A controlled field trial of live Salmonella Typhi strain Ty 21a oral vaccine against typhoid: three-year results. Journal of Infectious Diseases 1982; 145 292-295.
53. Chuttani CS, et al. Controlled field trial of high-dose oral killed typhoid vaccine in India. Bulletin of the World Health Organisation 1977; 55: 643-644.
54. Polish Typhoid Committee. Evaluation of typhoid vaccines in the laboratory and in a controlled field trial in Poland. Bull WHO 1965; 32: 15-27.
55. Hejfec LB, et al. A controlled field trial and laboratory study of five typhoid vaccines in the USSR. Bulletin of the World Health Organisation 1966; 34: 321-339.
56. Hejfec LB. Results of the study of typhoid vaccines in four controlled field trials mi the USSR. Bulletin of the World Health Organisation 1965; 32: 1-14.
57. Heffec LB, et al. Controlled field trials of paratyphoid B vaccine and evaluation of the effectiveness of a single administration of typhoid vaccine. Bulletin of the World Health Organisation 1968; 38: 907-915.
58. Hejfec LB, et al. A controlled field trial to evaluate the protective capacity of a single dose of acetone-killed agar-grown And heat-killed broth-grown typhoid vaccines. Bulletin of the World Health Organisation 1969;0 40: 903-907.
59. Yugoslav Typhoid Commission. A eontrolled field trial of the effectiveness of acetone-dried and inactivated and heat-phenol-inactivated typhoid vaccines in Yugoslavia. Bulletin of the World Health Organisation 1964; 30: 623-630.
60. Yugoslav Typhoid Commission. A controlled field trial of the effectiveness of phenol and alcohol typhoid vaccines. Bulletin of the World Health Organisation 1962; 26: 357-369.
61. Ashcroft MT, et al. A seven-year field trial of two typhoid vaccines in Guyana. Lapcet 1967; 2: 1056-1059.
62. Tapa S, Cvjetanovic B. Controlled field trial on the effectiveness of one and two doses of acetone-inactivated and dried typhoid vaccine. Bulletin of the World Health Organisation 1975; 52: 75-80.
63. Okome-Nkoumou M, et al. Typhoid and paratyphoid fever in adults in the internal medicine department at Libreville, Gabon. Sante 2000; 10: 205-209.
64. Ellis ME, Moosa A, Hillier V. A review of typhoid fever in South African black children. Postgraduate Medical Journal 1990; 66 1032-1036.
65. Topley JM. Mild typhoid fever. Archives of Diseases in Childhood 1986; 61: 164-167.
66. Wongsawat J, Pancharoen C, Thisyakorn U. Typhoid fever in children: Experience in King Chulalongkorn Memorial Hospital. Journal of the Medical Association of Thailand 2002; 85: 1247-1250.
67. Thisyakorn U, Mansuwan P, Taylor DN. Typhoid and paratyphoid fever in 192 hospitalized children in Thailand. American Journal of Diseases of Childhood 1987; 141: 862-865.
68. Chiu C-H, et al. Typhoid fever in children: A fourteen-year experience. Acta Paediatrica Taiwan 2000; 41: 28-32.
69. Hoa NTT, et al. Community-acquired septicaemia in southern, Viet Nam: The importance of multidrug-resistant Salmonella Typhi. Transactions of the Royal Society of Tropical Mediaine and Hygiene 1998; 92: 503-508.
70. Yap YF, Puthucheary SD. Typhoid fever in children: A retrospective study of 54 cases from Malaysia. Singapore Medical Journal 1998; 39: 260-262.
71. Choo KE, et al. Typhoid fever in hospitalized children in Kelantan, Malaysia. Annals of Tropical Paediatrics 1988; 8: 207-212.
72. Brown, GW, et al. Febrile illness in Malaysia: An analysis of 1,629 hospitalized patients. American Journal of Tropical Medicine and Hygiene 1984; 33: 311-315.
73. Bhutta ZA, et al. Multidrug-resistant typhoid in children: presentation and clinical features. Review of Infectious Diseases 1991; 13: 832-836.
74. Bhutta ZA. Therapeutic aspects of typlipidal salmonellosis in childhood: The Karachi experience. Annals of Tropical Paediatrics 1096; 16: 299-306.
75. Islam SS, Shahid NS. Morbidity and mortality in a diarrhoeal diseases, hospital in Bangladesh. Transactions of the Royal Society of Tropical Medicine and Hygiene 1986; 80: 748-752.
76. Abucejo PE, et al. Blood culture confirmed typhoid fever in a provincial hospital in the Philippines. Southeast Asian Journal of Tropical Medicine and Public Health 2001; 3: 531-536.
77. Secmeer G, et al. Salmonella Typhi infections. Turkish Journal of Pediatrics 1995; 37: 339-344.
78. Biswal N, et al. Enteric fever: A changing perspective. Indian Pediatrics 1994; 31: 813-819.
79. Rasaily R, et al. Multi-drug resistant typhoid fever in hospitalized children: Clinical, bacteriological and epidemiological profiles. European Journal of Epidemialogy 1994; 10: 41-46.
80. Rao PS, et al. Emergence of multidrug-resistant Salmonella Typhi in rural southern India. American Journal of Tropical Medicine and Hygiene 1993; 49: 108-111.
81. Gupta SP, et al. Current clinical patterns of typhoid fever: a prospective study. Journal of Tropical Medicine, and Hygiene 1985; 88: 377-381.
82. Olle-Goig JE, Ruiz L. Typhoid fever in rural Haiti. Bulletin PAHO 1993; 27: 382-388.
83. Richens J. Typhoid fever in the highlands of Papua New Guinea 1984-1990: A hospital-based perspective. PNG, Medical Journal, 1995; 38: 305-314.
84. Kizilcan F, et al. Complications of typhoid fever requiring laparotomy during childhood. Journal of Pediatric Surgery 1993; 28: 1490-1493.